Table 1.
Common Germline Predispositions in MDS and Acute Leukemias
Gene or Pathway* | Hematologic Malignancy | Additional Hematologic Abnormality | Other Malignancies | Additional Symptoms | Syndrome|| | Refs. |
---|---|---|---|---|---|---|
CEBPA | AML | No common abnormalities noted | No other malignancies are common | None observed | Familial acute myeloid leukemia with mutated CEBPA | 40–42 |
DDX41 | MDS and AML; less commonly lymphoma | Cytopenia | No other malignancies are common | None observed | Familial AML with mutated DDX41 | 14,63,64 |
ETV6 | ALL, MDS, AML | Thrombocytopenia and decreased platelet function | No other malignancies are common | None observed | Thrombocytopenia 5 (OMIM 616216) | 144,145,215 |
GATA2 | MDS and AML | Immunodeficiency, bone marrow failure, monocytopenia and B cell lymphopenia | No other malignancies are common | Lymphedema, pulmonary alveolar proteinosis and congenital deafness | Emberger Syndrome (OMIM 614038) and MonoMac Syndrome (OMIM 614172) | 46,245,246 |
IKZF1 | B-ALL, less commonly T-ALL | Immunodeficiency | No other malignancies are common | Autoimmunity | Not described | 8,206,207 |
PAX5 | B-ALL | No common abnormalities noted | No other malignancies are common | None observed | Not described | 12,166,178 |
RAS–MAPK pathway: CBL, NF1 and PTPN11 | JMML, ALL, AML | JMML-like proliferation with spontaneous regression | Neurofibroma and embryonal rhabdomyosarcoma | Cardiac abnormalities, skin manifestations, growth retardation and facial dysmorphologies | Noonan Syndrome (OMIM 163950); NF1 (OMIM 162200) and other RASopathies | 100;95,104;215 |
RUNX1 | MDS and AML, less commonly T-ALL | Thrombocytopenia and decreased platelet function | No other malignancies are common | None observed | Familial platelet disorder with propensity for myeloid malignancy (OMIM 601399) | 30,33,36 |
SAMD9 | MDS and AML with monosomy 7 | Bone marrow failure | No other malignancies are common | Normophosphatemic familiar tumoral calcinosis; congenital adrenal hypoplasia, enteropathy and genital abnormalities | MIRAGE Syndrome (OMIM 617053) and Myelodysplasia and Leukemia Syndrome with Monosomy 7(OMIM 252270) | 16,17,71 |
SAMD9L | MDS and AML with monosomy 7 | Systemic autoinflammatory disease and bone marrow failure | No other malignancies are common | Ataxia | Ataxia Pancytopenia Syndrome (OMIM 159550) and Myelodysplasia and Leukemia Syndrome with Monosomy 7 (OMIM 252270) | 18,19,70 |
TP53 | Low hypodiploid ALL, Therapy Related Myeloid Neoplasm | No common abnormalities noted | Osteosarcoma, breast cancer, soft tissue sarcoma, brain tumors and adrenocortical carcinoma | None observed | Li-Fraumeni syndrome (OMIM 151623) | 143,150,181 |
Trisomy 21 | AML and ALL | Transient abnormal myelopoiesis | No other malignancies are common | Mental retardation, cardiac abnormalities and facial dysmorphologies | Down syndrome (OMIM 190685) | 135 |
Only the major genes and pathways discussed in this Review are included in this table.
Online Mendelian Inheritance in Man (OMIM) numbers are given for each syndrome, when applicable: https://www.omim.org/